| Vancomycin area under the curve and acute kidney injury: a meta-analysis DM Aljefri, SN Avedissian, NJ Rhodes, MJ Postelnick, K Nguyen, ... Clinical Infectious Diseases 69 (11), 1881-1887, 2019 | 158 | 2019 |
| Prolonged infusion piperacillin-tazobactam decreases mortality and improves outcomes in severely ill patients: results of a systematic review and meta-analysis NJ Rhodes, J Liu, JN O’Donnell, JM Dulhunty, MH Abdul-Aziz, PY Berko, ... Critical care medicine 46 (2), 236-243, 2018 | 107 | 2018 |
| A review of the clinical pharmacokinetics of polymyxin B SN Avedissian, J Liu, NJ Rhodes, A Lee, GM Pais, AR Hauser, ... Antibiotics 8 (1), 31, 2019 | 87 | 2019 |
| Treatment outcomes with cefazolin versus oxacillin for deep-seated methicillin-susceptible Staphylococcus aureus bloodstream infections SN Rao, NJ Rhodes, BJ Lee, MH Scheetz, AP Hanson, J Segreti, ... Antimicrobial agents and chemotherapy 59 (9), 5232-5238, 2015 | 87 | 2015 |
| Population pharmacokinetics of polymyxin B in acutely ill adult patients C Miglis, NJ Rhodes, SN Avedissian, CJ Kubin, MT Yin, BC Nelson, ... Antimicrobial Agents and Chemotherapy 62 (3), 10.1128/aac. 01475-17, 2018 | 81 | 2018 |
| Vancomycin‐induced kidney injury: animal models of toxicodynamics, mechanisms of injury, human translation, and potential strategies for prevention GM Pais, J Liu, S Zepcan, SN Avedissian, NJ Rhodes, KJ Downes, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40 (5 …, 2020 | 66 | 2020 |
| Evaluation of vancomycin exposures associated with elevations in novel urinary biomarkers of acute kidney injury in vancomycin-treated rats NJ Rhodes, WC Prozialeck, TP Lodise, N Venkatesan, JN O'Donnell, ... Antimicrobial agents and chemotherapy 60 (10), 5742-5751, 2016 | 63 | 2016 |
| β-Lactam pharmacodynamics in Gram-negative bloodstream infections in the critically ill G Wong, F Taccone, P Villois, MH Scheetz, NJ Rhodes, S Briscoe, ... Journal of Antimicrobial Chemotherapy 75 (2), 429-433, 2020 | 61 | 2020 |
| Defining clinical exposures of cefepime for Gram-negative bloodstream infections that are associated with improved survival NJ Rhodes, JL Kuti, DP Nicolau, S Van Wart, AM Nicasio, J Liu, BJ Lee, ... Antimicrobial agents and chemotherapy 60 (3), 1401-1410, 2016 | 61 | 2016 |
| Resistance trends and treatment options in gram-negative ventilator-associated pneumonia NJ Rhodes, CE Cruce, JN O’Donnell, RG Wunderink, AR Hauser Current infectious disease reports 20, 1-15, 2018 | 56 | 2018 |
| Impact of loading doses on the time to adequate predicted beta-lactam concentrations in prolonged and continuous infusion dosing schemes NJ Rhodes, SH MacVane, JL Kuti, MH Scheetz Clinical infectious diseases 59 (6), 905-907, 2014 | 54 | 2014 |
| Population pharmacokinetics of intravenous polymyxin B from clinical samples CJ Kubin, BC Nelson, C Miglis, MH Scheetz, NJ Rhodes, SN Avedissian, ... Antimicrobial Agents and Chemotherapy 62 (3), 10.1128/aac. 01493-17, 2018 | 52 | 2018 |
| 24-hour pharmacokinetic relationships for vancomycin and novel urinary biomarkers of acute kidney injury JN O'Donnell, NJ Rhodes, TP Lodise, WC Prozialeck, CM Miglis, ... Antimicrobial agents and chemotherapy 61 (11), 10.1128/aac. 00416-17, 2017 | 49 | 2017 |
| Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxis NJ Rhodes, BJ Gardiner, MN Neely, ML Grayson, AG Ellis, ... Journal of antimicrobial chemotherapy 70 (7), 2068-2073, 2015 | 49 | 2015 |
| Lack of synergistic nephrotoxicity between vancomycin and piperacillin/tazobactam in a rat model and a confirmatory cellular model GM Pais, J Liu, SN Avedissian, D Hiner, T Xanthos, A Chalkias, E d’Aloja, ... Journal of antimicrobial chemotherapy 75 (5), 1228-1236, 2020 | 46 | 2020 |
| Polymyxin B pharmacokinetics in adult cystic fibrosis patients SN Avedissian, C Miglis, CJ Kubin, NJ Rhodes, MT Yin, S Cremers, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38 (7 …, 2018 | 45 | 2018 |
| Student characteristics associated with successful matching to a PGY1 residency program JA Phillips, MM McLaughlin, C Rose, JC Gallagher, JP Gettig, NJ Rhodes American Journal of Pharmaceutical Education 80 (5), 84, 2016 | 44 | 2016 |
| Piperacillin-tazobactam added to vancomycin increases risk for acute kidney injury: fact or fiction? SN Avedissian, GM Pais, J Liu, NJ Rhodes, MH Scheetz Clinical infectious diseases 71 (2), 426-432, 2020 | 42 | 2020 |
| Comparative performance of urinary biomarkers for vancomycin-induced kidney injury according to timeline of injury GM Pais, SN Avedissian, JN O’Donnell, NJ Rhodes, TP Lodise, ... Antimicrobial agents and chemotherapy 63 (7), 10.1128/aac. 00079-19, 2019 | 42 | 2019 |
| An exploratory analysis of the ability of a cefepime trough concentration greater than 22 mg/L to predict neurotoxicity NJ Rhodes, JL Kuti, DP Nicolau, MN Neely, AM Nicasio, MH Scheetz Journal of Infection and Chemotherapy 22 (2), 78-83, 2016 | 37 | 2016 |
Marc H. ScheetzProfessor of Pharmacy and Pharmacology, Midwestern University, Colleges of Pharmacy and Graduate在 midwestern.edu 的电子邮件经过验证
